Proteostasis Therapeutics Investors
Proteostasis Therapeutics is a venture capital fund based in Cambridge, Massachusetts, founded in 2007 The firm specializes in investing in innovative biopharmaceutical companies focused on the modulation of protein homeostasis With a significant investment scale of $50,000,000, Proteostasis Therapeutics aims to advance novel therapeutic approaches for diseases associated with protein misfolding and aggregation The fund is committed to supporting early-stage companies that demonstrate potential for transformative impact in the healthcare sector Through strategic investments, Proteostasis Therapeutics seeks to foster advancements in drug development and improve patient outcomes
Investors
Industry:
FemTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2007
Investor Type:
Venture Capital Funds
Register and Claim Ownership